Zentalis Pharmaceuticals (ZNTL) Leases (2022 - 2025)
Historic Leases for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to $30.2 million.
- Zentalis Pharmaceuticals' Leases fell 962.49% to $30.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 million, marking a year-over-year decrease of 962.49%. This contributed to the annual value of $32.5 million for FY2024, which is 943.31% down from last year.
- Zentalis Pharmaceuticals' Leases amounted to $30.2 million in Q3 2025, which was down 962.49% from $31.2 million recorded in Q2 2025.
- Over the past 5 years, Zentalis Pharmaceuticals' Leases peaked at $43.6 million during Q1 2022, and registered a low of $30.2 million during Q3 2025.
- Its 4-year average for Leases is $36.4 million, with a median of $35.9 million in 2023.
- Its Leases has fluctuated over the past 5 years, first plummeted by 1552.01% in 2023, then plummeted by 686.8% in 2025.
- Zentalis Pharmaceuticals' Leases (Quarter) stood at $42.4 million in 2022, then fell by 15.24% to $35.9 million in 2023, then decreased by 9.43% to $32.5 million in 2024, then dropped by 7.19% to $30.2 million in 2025.
- Its last three reported values are $30.2 million in Q3 2025, $31.2 million for Q2 2025, and $31.9 million during Q1 2025.